Smith Asset Management Group »

Fate Therapeutics shares owned by Smith Asset Management Group

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Smith Asset Management Group from 13F filings

Historical chart of Smith Asset Management Group investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Smith Asset Management Group

Quarter filed Position value Share count Share price at filing
2021-06-30 $8.0k 90 88.89
2021-03-31 $7.0k 90 77.78
2020-12-31 $235k 2.6k 91.09
2020-09-30 $103k 2.6k 39.92

More positions owned by Smith Asset Management Group

Apple Common Stock - Long (AAPL)
Microsoft Corp Common Stock - Long (MSFT)
Amazon.com Common Stock - Long (AMZN)
Facebook Common Stock - Long (META)
Alphabet Common Stock - Long (GOOGL)
Nvidia Corp Common Stock - Long (NVDA)
Fortinet Common Stock - Long (FTNT)
Adobe Common Stock - Long (ADBE)
United Parcel Service Common Stock - Long (UPS)
Jpmorgan Chase & Co Common Stock - Long (JPM)
Parker-Hannifin Corp Common Stock - Long (PH)
Target Corp Common Stock - Long (TGT)
Capital One Financial Corp Common Stock - Long (COF)
Paypal Holdings Common Stock - Long (PYPL)
Epam Systems Common Stock - Long (EPAM)

View all positions for Smith Asset Management Group

Top funds holding Fate Therapeutics

Redmile Group
Vanguard Group
BlackRock
Bellevue Group
D. E. Shaw & Co
Point72 Asset Management
Johnson & Johnson
Citadel Advisors
Jacobs Levy Equity Management
Assenagon Asset Management
Casdin Capital
Two Sigma Advisers
Federated Investors
Jpmorgan Chase & Co
Acadian Asset Management

View all funds holding Fate Therapeutics